MSH2 and Huntington disease: Experimentally, in mouse models of HD, there is long-standing evidence that reduced expression of the MMR proteins Msh2, Msh3, Mlh1 or Mlh3 counteracts somatic CAG repeat expansion23,24 and de-escalates the HD experimental pathogenic process25.